Cellular Bioengineering Inc entered the industry of Medical Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417113, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Hank Wuh, Chief Executive Officer by calling (808) 949-2208 during business hours. You can also write to the business’ Single Location at 650 Iwilei Road, Honolulu, Hawaii HI 96817. You can also visit the company’s website at eyegenix.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Cellular Bioengineering Inc |
Representative: | Hank Wuh, Chief Executive Officer |
Place of Business: | 650 Iwilei Road, Honolulu, HI 96817 |
Contact Number: | (808) 949-2208 |
Website: | eyegenix.com |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 5417113 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2003 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Cellular Bioengineering Inc is a company operating from Honolulu, Hawaii providing professional Medical Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417113 as Medical Research.
With a current employee count of 1 to 4, Cellular Bioengineering Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Hank Wuh, Chief Executive Officer at (808) 949-2208 for related queries, or to locate its Single Location using the coordinates 21.31622,-157.86997.
The Single Location can also be found at the street address 650 Iwilei Road in Honolulu, Hawaii 96817 and can be engaged online through the company website at eyegenix.com, the company Twitter , and Facebook page .